One of the technology driving the revolution in the In-Situ Hybridization Market is multiplexed fluorescent ISH. Traditionally, ISH was limited to visualizing one or two targets simultaneously. However, multiplexed ISH allows the detection of multiple nucleic acid targets within a single tissue section. This advancement is made possible by the development of fluorophore-conjugated probes with distinct emission spectra. Multiplexed ISH facilitates the study of complex biological processes, gene regulatory networks, and spatial interactions between genes. It also enhances the diagnostic capabilities by enabling the simultaneous detection of multiple biomarkers in diseases such as cancer, neurodegenerative disorders, and infectious diseases.
Explore More https://cmi-latestreportorientedblogs.blogspot.com/2023/05/global-in-situ-hybridization-market-is.html
